Ballester A, Tobeña R, Lisbona C, Calvo V, Alemany S
Instituto de Investigaciones Biomedicas, Consejo Superior de Investigaciones Cientificas, Facultad de Medicina Universidad Autónoma de Madrid, Spain.
J Immunol. 1997 Aug 15;159(4):1613-8.
tpl-2 is a rat gene that encodes a serine/threonine protein kinase that can act as a novel mitogen-activated protein (MAP) kinase kinase kinase. Tpl-2 is activated in Moloney murine leukemia virus-induced rat T lymphomas, due to a truncation in the C-terminal region of the protein. cot is a very closely related gene, if not the human homologue. The truncated form of Cot has been shown to have a higher transforming activity than the nontruncated form. In this paper we show that an increase in truncated Cot kinase expression correlates with an increase in IL-2 production in anti-CD3-treated Jurkat cells. Truncated Cot expression also cooperates with PHA or phorbol 12,13-dibutyrate (PDBu) and calcium ionophore for IL-2 production in Jurkat cells. Both the truncated and nontruncated Cot forms increased IL-2 transcription because they enhanced transcription of a reporter gene linked to the IL-2 promoter. The expression of a dominant negative form of Cot inhibits transcription directed by the IL-2 promoter in Jurkat cells stimulated by PDBu and ionophore. These data suggest a role of Tpl-2/Cot kinase in IL-2 production during T lymphocyte activation and could also explain its role in Moloney murine leukemia virus-induced lymphomagenesis.
Tpl-2是一种大鼠基因,它编码一种丝氨酸/苏氨酸蛋白激酶,可作为一种新型的丝裂原活化蛋白(MAP)激酶激酶激酶。由于该蛋白C末端区域的截短,Tpl-2在莫洛尼鼠白血病病毒诱导的大鼠T淋巴瘤中被激活。Cot是一个与之密切相关的基因,即便不是人类同源基因。已证明截短形式的Cot比未截短形式具有更高的转化活性。在本文中,我们表明在抗CD3处理的Jurkat细胞中,截短的Cot激酶表达增加与白细胞介素-2(IL-2)产生增加相关。截短的Cot表达还与植物血凝素(PHA)或佛波醇12,13-二丁酸酯(PDBu)以及钙离子载体协同作用,促进Jurkat细胞产生IL-2。截短和未截短的Cot形式均增加了IL-2转录,因为它们增强了与IL-2启动子相连的报告基因的转录。Cot显性负性形式的表达抑制了在PDBu和离子载体刺激的Jurkat细胞中由IL-2启动子指导的转录。这些数据表明Tpl-2/Cot激酶在T淋巴细胞活化过程中IL-2产生中发挥作用,这也可以解释其在莫洛尼鼠白血病病毒诱导的淋巴瘤发生中的作用。